Table 3.
compd | R1 | R2 | IC50 AC50 ± SD [μM]a |
Hill coeff b | % Activity ESIc |
---|---|---|---|---|---|
Negative allosteric modulators | |||||
2 | 2-CH3, 5-CH3 | 4-Morpholine | 6.4 ± 0.5 | 1.36 ± 0.13 | 31.4 ± 1.3 |
2a | 2-CH3, 4-CH3 | 4-Morpholine | 11.7 ± 1.8 | 2.01 ± 0.08 | 69.8 ± 0.7 |
2c | H | H | 10.6 ± 0.8 | 2.45 ± 0.34 | 38.6 ± 2.1 |
2d | 4-CH3 | 4-Morpholine | 207.0 ± 77.8 | 2.42 ± 1.35 | 42.2 ± 9.3 |
2e | 2-CH3 | 4-Morpholine | 2.2 ± 0.5 | 2.34 ± 1.04 | 63.3 ± 8.5 |
2f | 2-CH3, 5-CH3 | 3-COCH3 | 127.3 ± 0.9 | 1.29 ± 0.10 | 5.9 ± 0.4 |
2g | H | 4-NHCOCH3 | 620.3 ± 77.2 | 1.19 ± 0.10 | 8.3 ± 2.5 |
2h | 4-OCH3 | 4-NHCO(C3H5) | 271.1 ± 13.9 | 0.96 ± 0.07 | 1.2 ± 0.0 |
2i | H | 4-N(CH3)2 | 4.4 ± 2.2 | 2.05 ± 0.12 | 92.2 ± 0.6 |
Silent allosteric modulator | |||||
2j | H | 4-Morpholine | 12.1 ± 5.2 | 1.99 ± 0.04 | 95.5 ± 0.1 |
Positive allosteric modulators | |||||
2k | H | 2-Morpholine | 69.9 ± 5.8 | 2.87 ± 0.61 | 172.6 ± 2.4 |
2l | 4-OCH3 | 2-Morpholine | 46.8 ± 3.4 | 2.84 ± 0.46 | 167.3 ± 2.2 |
2m | H | 3-Sulfonyl-morpholine | 25.0 ± 5.3 | 2.06 ± 0.15 | 142.0 ± 1.4 |
2n | 4-tBu | 2-Hydroxyl, 5-Sulfonylmorpholine | 25.4 ± 3.5 | 2.08 ± 0.51 | 146.5 ± 4.4 |
2b | H | 2-OCH3, 5-Sulfonylmorpholine | 12.5 ± 1.0 | 1.62 ± 0.04 | 147.8 ± 3.7 |
All experiments to determine IC50 and AC50 values were run with at least duplicates at each compound dilution, IC50 and AC50 values were averaged when determined in two or more independent experiments.
Hill coefficient obtained upon fitting the concentration-response curves.
DGC activity of the enzyme-substrate-inhibitor complex.